An Overview of Drug Resistance in Protozoal Diseases
Protozoan diseases continue to be a worldwide social and economic health problem. Increased drug resistance, emerging cross resistance, and lack of new drugs with novel mechanisms of action significantly reduce the effectiveness of current antiprotozoal therapies. While drug resistance associated to...
Main Authors: | Rita Capela, Rui Moreira, Francisca Lopes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/22/5748 |
Similar Items
-
Protein structure-based design of anti-protozoal drugs
by: Verlinde Christophe L. M. J., et al.
Published: (2002-01-01) -
Recent Advances in the Discovery of Novel Antiprotozoal Agents
by: Seong-Min Lee, et al.
Published: (2019-10-01) -
Ocular parasitosis caused by protozoan infection during travel: Focus on prevention and treatment
by: Morteza Izadi, et al.
Published: (2018-01-01) -
Leptin Functions in Infectious Diseases
by: Radheshyam Maurya, et al.
Published: (2018-11-01) -
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
by: Violeta Kourbeli, et al.
Published: (2021-07-01)